Lisa McClain (R-MI)

Accountability in Foreign Animal Research Act

H.R. 3043 · House bill Health

A Republican bill with 3 Democratic cosponsors · See all 10 cosponsors

Last activity — Referred to the House Committee on Energy and Commerce.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, called the "Accountability in Foreign Animal Research Act," aims to prevent taxpayer dollars from being used for animal experimentation in labs located in or controlled by specific foreign countries, including China, Iran, North Korea, and Russia. It also allows the Secretary of Health and Human Services to add other countries of concern to the list. The Secretary of Health and Human Services must report to Congress when a country is added to the list.

Yes

  • Scored +3

    Does this make what the government does easier for the public to see?

    The bill improves government transparency by requiring the Secretary of Health and Human Services to report to Congress on additions to the list of foreign countries.

  • Scored +1

    Does this give the federal government more power?

    The bill increases federal power by giving the Secretary of Health and Human Services the authority to restrict funding to foreign countries.

The opposite· 3 of 7

  • Scored -2

    Does this put more money into medical research?

    The bill may hinder some research by limiting where funds can be spent, which might slow the development of new treatments.

  • Scored -2

    Does this favour talking over confrontation abroad?

    The bill could strain diplomatic relations with countries where research is restricted.

  • Scored -1

    Would people over 65 be better off under this?

    If research is slowed down, potential future treatments for age-related diseases could be delayed, negatively affecting seniors.